Not Signed In - H. Lee Moffitt Researchers Discover Potential Targets To Reduce Risk Of Stem Cell Transplants
Wed, 21 Feb 2007 08:00 AM EST
... Inhibiting one gene -- even temporarily -- can improve cure rates for blood cancer patients who receive stem cell transplants. This strategy may also help patients with genetic and autoimmune diseases who are also treated with stem cell transplants. Researchers at H. Lee Moffitt Comprehensive Cancer Center in Tampa, led by William Kerr Ph.D. [click link for full article] ...
Related Topics
- Stem Cell Research
- Stem Cells/Stem Cell Transplantation
- Stem Cells and Stem Cell Transplantation
- Peripheral Blood Stem Cells
- Primary Amebic Meningoencephalitis
- Transplantation
- Risk Factors
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- Blood Cells
- Sickle Cell Anemia
- Security Risk Assessment
- Cardiac Risk
- High Risk Pregnancy
- Small Cell Lung Cancer
- Sickle Cell
- Skin Cancer
- Ovarian Low Malignant Potential Tumors
- Ovarian Low Malignant Potential Tumor
- Youth Risk Behaviors
- Renal Cell Cancer
email this page
print this page
bookmark this page
feedback on this page
